NOVARTIS AG CEDEAR EAC 4 REP 1(USD) financial statements, including revenue, expenses, profit, and loss
The total revenue of NVSD for the last quarter is 12.59 B USD, and it's 9.79% higher compared to the previous quarter. The net income of Q2 24 is 3.27 B USD.